Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Mar 16, 2015, after the close
10-K filed Mar 16, 2015, 75 days after period end · 0001144204-15-016085
| Metric | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011dderived from reported figures |
|---|---|---|---|---|
| Revenue | $4.67K | $2.50K | $2.50K | — |
| Net Income | -$5.50M | -$3.30M | -$2.71M | -$2.56M |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| EPS Diluted | -$0.06 | -$0.04 | -$0.04 | — |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
